您的位置: 首页 > 农业专利 > 详情页

3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives as C-Met tyrosine kinase modulators
专利权人:
Novartis AG
发明人:
Furet, Pascal,McCarthy, Clive,Schoepfer, Joseph,Stutz, Stefan
申请号:
AU2010280706
公开号:
AU2010280706A1
申请日:
2010.08.06
申请国别(地区):
AU
年份:
2012
代理人:
摘要:
The invention relates to compounds of formula (I) and salts thereof, wherein the substituents are as defined in the specification, the application of a compound of formula (I) in a process for the treatment of the human or animal body, in particular with regard to C-Met tyrosine kinase mediated disease; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharamaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner; processes for the preparation of a compound of formula (I).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充